Skip to main content
S&P 5007,743.98+0.28%DOW52,475.10+0.19%NASDAQ26,549.85+0.27%BTC$80,090.00-0.66%ETH$2,324.58-0.50%GOLD$4,030.30-0.53%OIL$101.40-1.34%
Smart Investors Daily
SID Premium
LF

NASDAQ · LFCR

Lifecore Biomedical, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

$6.51

Up+$0.07 (+1.09%)

Updated Oct 29, 2026, 12:20 PM

SID Score

4.3/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
292.19M
P/E ratio
-7.47
Dividend yield
0.00%
52-week range
$3.63 – $8.98
Volume
365.16K
Avg. volume
177.01K

Price performance · LFCR

LFCR price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Oct 28, 2026

LFCR closed at $6.51 after 21 trading sessions, down 1.06% for the selected period.

Last close
$6.51
Period change
-1.06%
Period low
$6.37
Period high
$6.58
Daily close
View OHLC price history
LFCR OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 28, 2026$6.44$6.51$6.43$6.51365.16K
Oct 27, 2026$6.36$6.44$6.36$6.44441.61K
Oct 26, 2026$6.41$6.44$6.40$6.44436.37K
Oct 23, 2026$6.36$6.40$6.36$6.40224.04K
Oct 22, 2026$6.37$6.39$6.36$6.37178.73K
Oct 21, 2026$6.40$6.40$6.36$6.37270.38K
Oct 20, 2026$6.38$6.40$6.37$6.37588.3K
Oct 19, 2026$6.38$6.415$6.38$6.39229.88K
Oct 16, 2026$6.42$6.44$6.38$6.381.43M
Oct 15, 2026$6.44$6.48$6.42$6.44233.44K
Oct 14, 2026$6.40$6.44$6.40$6.42267.97K
Oct 13, 2026$6.46$6.46$6.40$6.42590.77K
Oct 12, 2026$6.45$6.46$6.43$6.44312K
Oct 9, 2026$6.43$6.46$6.42$6.45387.1K
Oct 8, 2026$6.43$6.455$6.42$6.43492.06K
Oct 7, 2026$6.45$6.48$6.43$6.441.72M
Oct 6, 2026$6.51$6.54$6.44$6.451.23M
Oct 5, 2026$6.54$6.565$6.51$6.52840.59K
Oct 2, 2026$6.55$6.55$6.53$6.54504.72K
Oct 1, 2026$6.57$6.58$6.53$6.53707.1K
Sep 30, 2026$6.55$6.61$6.54$6.58970.23K

Latest LFCR news

The latest Smart Investors Daily articles mentioning LFCR.

Stock researchCompany · Overview

LFCR research

Overview

Company profile and research snapshot.

Company profile

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$6.50
Implied upside
—
Analysts
11
LFCR recent ratings
DateFirmRatingTarget
Sep 29, 2026Barrington ResearchMarket Perform—
Sep 28, 2026William BlairMarket Perform—
Jun 16, 2026Barrington ResearchOutperform—
Apr 29, 2026Barrington ResearchOutperform—
Mar 27, 2026Barrington ResearchOutperform—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 26, 2026

Braemar Unveils Highly Qualified Independent Board Slate for Company’s New Chapter

DALLAS, October 26, 2026--Braemar Hotels & Resorts Inc. (NYSE: BHR) ("Braemar" or the "Company") today announced that its Board of Directors (the "Board") intends to nominate eight highly qualified, seasoned leaders for election at the Company’s 2026 Annual Meeting of Stockholders (the "Annual Meeting"). The slate of eight director candidates includes seven new, highly qualified and independent director nominees:

Yahoo · Oct 23, 2026

Is Lifecore Biomedical (LFCR) an Asymmetric Risk-Reward in Pharma Contract Manufacturing?

Diranko Capital, an independent investment management firm, released its Q3 2026 investor letter. The letter can be downloaded here. In the quarter, Diranko Capital achieved a 2.2% after-fee return, matching the MSCI ACWI and outperforming the MSCI World Small Cap (-2.9%). Since inception, the firm has delivered a 14.7% annualized after-fee return, exceeding both benchmark […]

Benzinga · Oct 8, 2026

Lifecore Biomedical Q2 2026 Earnings Call Transcript

Lifecore Biomedical (NASDAQ:LFCR) held its second-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. This content is powered by Benzinga APIs. For comprehensive financial data

Yahoo · Oct 7, 2026

Lifecore Biomedical to Participate at Upcoming Industry Conferences

CHASKA, Minn., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced that the company will participate at three upcoming industry events. At each conference, Lifecore leaders will host meetings with prospective customers to discuss process development and manufacturing services for injectable programs. Details regarding Lifecore’s participation are as fo

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By